Hepatitis B is an acute viral infection of the liver caused by the hepatitis B virus (HBV), which can progress to chronic infection and lead to serious complications such as liver cirrhosis and hepatocellular carcinoma [1]. The virus is primarily transmitted through infected blood and other body fluids, including vertical transmission (mother-to-child), sexual contact, unsafe injections, blood transfusions, and dialysis [2]. Despite the availability of an effective vaccine, HBV infection remains a major global public health problem, particularly in Africa. In 2022, it was estimated that approximately 254 million people worldwide were living with chronic HBV infection, with nearly 1.1 million deaths annually, mainly due to cirrhosis and primary liver cancer [3]. Sub-Saharan Africa bears a disproportionate burden, with about 60 million chronically infected individuals, and HBV-related liver cancers accounting for nearly 600,000 deaths worldwide each year [4][5]. Individuals infected with HBV are at high risk of developing chronic disease and long-term hepatic complications, particularly in settings with limited access to early diagnosis and care [6]. In sub-Saharan Africa, the residual risk of HBV transmission remains a major concern due to the high prevalence of blood-borne infectious agents and inadequate blood donor selection processes [7]. Current HBV screening strategies used by blood banks are generally based on the detection of hepatitis B surface antigen (HBsAg) and, in some settings, antibodies to hepatitis B core antigen (anti-HBc) [8]. Blood transfusion is a common medical practice in the Republic of Guinea and continues to represent a significant risk factor for HBV transmission from donors to recipients. In this context, and in order to contribute to improving blood donor selection criteria particularly in regions outside Conakry where pre-donation screening and monitoring measures remain limited and given the lack of previous studies in this setting, the present study was conducted to assess the seroprevalence and factors associated with hepatitis B virus carriage among blood donors.

A total of 307 blood donors were included in the study, of whom 278 (90.6%) were seronegative and 29 (9.4%) were seropositive (Table 1). The study population was predominantly male (67.8%), with a mean age of 31 ± 9 years. No statistically significant differences were observed between seronegative and seropositive donors in terms of gender (p = 0.3) or mean age (p = 0.3). In terms of education level, 62.5% of participants had no schooling, with no significant difference between the groups (p = 0.2). The most common occupations were military personnel (37.5%) and drivers (25.7%), with no significant association with HIV status (p > 0.9). The majority of donors were married (59.0%), and 78.5% resided in Coyah. Marital status and place of residence were not significantly associated with HIV-positive status (p > 0.3).

Table 1. Sociodemographic and clinical characteristics of blood donors.

Continued

The results of the univariate and multivariate logistic regression analyses are presented in Table 2. In the univariate analysis, donors aged 31 - 40 had a significantly higher risk of HIV positivity compared to the reference group aged 18 - 30 (OR = 2.67; 95% CI [1.64 - 4.39]; p < 0.001). Similarly, risky sexual behaviors were significantly associated with HIV positivity (OR = 1.82; 95% CI [1.10 - 3.02]; p = 0.020). HIV infection was also strongly associated with HIV-positive status (OR = 5.78; 95% CI [1.86 - 25.4]; p = 0.006). After adjustment in the multivariate model, several factors remained independently associated with HIV-positive status. The 31 - 40 age group (OR = 6.14; 95% CI [3.19 - 12.5]; p < 0.001) and the 51 - 60 age group (OR = 7.83; 95% CI [2.29 - 29.8]; p = 0.001) had a significantly increased risk. Educated participants had a significantly lower risk of HIV infection (OR = 0.36; 95% CI [0.20 - 0.63]; p < 0.001). Risky sexual behaviors remained strongly associated with HIV infection (OR = 6.26; 95% CI [3.09 - 13.3]; p < 0.001), as was HIV infection (OR = 10.2; 95% CI [2.71 - 52.7]; p = 0.002).

Table 2. Results of multivariate logistic regression analysis.

Continued

Abbreviations: CI = Confidence Interval, OR = Odds Ratio.

Our descriptive cross-sectional study with an analytical component was conducted prospectively over a three-month period and included a total of 307 blood donors. Blood samples were collected from donors at the Blood Transfusion Unit of Coyah Prefectural Hospital (UHTS). During the study period, all 307 donors met the inclusion criteria. Donors aged 18 - 28 years constituted the largest age group, followed by those aged 29 - 39 years, accounting for 59.6% and 28.7% of the study population, respectively, and representing a combined proportion of 88.3% of the total sample. These findings are consistent with those reported by Maiga et al. in 2024 in Mali [9], who reported a mean age of 38.5 years, reflecting a predominantly young donor population. This distribution is commonly observed in blood transfusion settings, where donors are more frequently recruited from younger age groups.

In our study, male donors were more represented, accounting for 67.8% of the sample, which corroborates the findings of Gake et al. [10]. in 2024 in Cameroon, who reported a male-to-female ratio of 1.48 in favor of males. This predominance of male donors may be explained by several physiological factors that limit female eligibility for blood donation, such as menstruation, pregnancy, and breastfeeding.

Regarding occupation, manual workers were the most represented group (37.5%), similar to the findings of Maquessene et al. [11] in 2025, in which the majority of donors did not attend school or had only completed secondary education. The study found 29 cases positive for HBsAg, with a prevalence of 9.4%. These results were significantly higher than those found by Mody et al. [12] n 2023 in Guinea, who reported an HBsAg prevalence of 4% in a sample of 250 donors. This difference could be explained by the sample size.

The frequency of HBsAg was higher in men than in women, at 10.5% and 7.0%, respectively. The same observation was made by Gake et al. [10] in 2024. This could be explained by the fact that men are more likely to require blood transfusions than women, as certain physiological situations such as breastfeeding, pregnancy, menstruation, and hormonal factors could cause women to eliminate HBV more readily, explaining the difference between the two sexes. Despite this disparity observed in our study, the chi-square statistical analysis did not show a significant difference, with a p-value of 0.3. The prevalence of HBsAg was higher among donors aged 18 - 28 years (41.4%) and 29 - 39 years (51.7%). The same observation was made by Loua et al. in 2011 among blood donors at the National Blood Transfusion Center in Conakry, where the prevalence was 15.77% in the 18 - 29 age group [13]. This could be explained by the fact that these age groups represent the most sexually active population.

The HBsAg rate was significantly higher among individuals with no education (72.4%), which could be explained by the fact that these individuals receive less information about the disease and therefore do not take or apply preventive measures. Four (4) donors, representing 13.8% of HBsAg-positive patients, had co-infection with HIV and hepatitis, and HIV-infected donors had more hepatitis B virus infections, with a p-value of less than 0.05. Our prevalence was higher than that reported by Sylvestre et al. in 2022, which was 6.47% [14]. This could be explained by the fact that the two viruses share the same routes of transmission, and the difference could also be explained by the difference in sample size between the two studies.

One limitation of this study is the probable underestimation of the seroprevalence of viral hepatitis B. The absence of additional HBV marker testing, particularly viral load by PCR, did not allow for the identification of occult hepatitis B characterized by HBsAg negativity, which could have altered the overall estimate of seroprevalence among blood donors and also the size of our sample.

Our study on the prevalence of HBsAg among blood donors at the blood transfusion unit of Coyah Prefectural Hospital (UHTs) found a hospital frequency of 9.4%. The majority of donors were men. The frequency of HBV + HIV co-infection was 13.8%. Despite the existence of a safe and effective vaccine and molecules that are active against the virus, hepatitis B remains a real public health problem in Africa. This result is of great importance for prevention strategies, hence the need to strengthen HBV information, education, and communication programs.